Catalyst Pharmaceuticals Inc (CPRX) earnings · rev $589.0M
These earnings events as JSON? API free 100/dayCatalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
This CPRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CPRX revenue for 2025-12-31 was $589.0M. Net income was $214.3M. Revenue was up 19.8% from 2024-12-31 to 2025-12-31. CPRX currently screens at market cap $3.84B.
When the next CPRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 19.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CPRX research stays on the stock page; the tape stays on the quote page.
CPRX earnings FAQ
What are CPRX's latest revenue and net income?
Latest cached Catalyst Pharmaceuticals Inc (CPRX) revenue for Dec 31, 2025 was $589.0M. Net income was $214.3M. Statements: https://lician.com/financials/cprx
What is CPRX's latest diluted EPS?
Latest cached Catalyst Pharmaceuticals Inc (CPRX) diluted EPS for Dec 31, 2025 was $1.68.
What period does the latest CPRX earnings print cover?
The latest cached Catalyst Pharmaceuticals Inc (CPRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CPRX revenue change from the prior cached period?
Cached Catalyst Pharmaceuticals Inc (CPRX) revenue was up 19.8% from $491.7M (Dec 31, 2024) to $589.0M (Dec 31, 2025). Statements: https://lician.com/financials/cprx
Where are CPRX earnings listed?
Cached earnings facts for Catalyst Pharmaceuticals Inc (CPRX) are listed at https://lician.com/earnings/cprx. Statements: https://lician.com/financials/cprx
Not investment advice.